Dimerix Limited (DXB.AX)
AUD 0.32
(-5.88%)
AUD 0.32
(-5.88%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 13.89 Million AUD | 17.79% |
| 2023 | 11.79 Million AUD | 468.57% |
| 2022 | 2.07 Million AUD | -73.91% |
| 2021 | 7.95 Million AUD | 202.39% |
| 2020 | 2.62 Million AUD | 256.45% |
| 2019 | 737.76 Thousand AUD | 81.38% |
| 2018 | 406.74 Thousand AUD | 67.99% |
| 2017 | 242.11 Thousand AUD | -14.36% |
| 2016 | 282.72 Thousand AUD | 47.53% |
| 2015 | 191.64 Thousand AUD | 455.57% |
| 2014 | 34.49 Thousand AUD | -25.51% |
| 2013 | 46.3 Thousand AUD | 34.13% |
| 2012 | 34.52 Thousand AUD | 23.36% |
| 2011 | 27.98 Thousand AUD | -39.62% |
| 2010 | 46.34 Thousand AUD | 6.9% |
| 2009 | 43.35 Thousand AUD | -96.99% |
| 2008 | 1.44 Million AUD | -45.78% |
| 2007 | 2.65 Million AUD | 672.86% |
| 2006 | 343.75 Thousand AUD | 42.94% |
| 2005 | 240.49 Thousand AUD | -87.96% |
| 2004 | 1.99 Million AUD | 12.17% |
| 2003 | 1.78 Million AUD | 10.79% |
| 2002 | 1.6 Million AUD | -1.83% |
| 2001 | 1.63 Million AUD | -38.46% |
| 2000 | 2.66 Million AUD | -20.55% |
| 1999 | 3.34 Million AUD | -28.18% |
| 1998 | 4.66 Million AUD | 1438.11% |
| 1997 | 303.21 Thousand AUD | -23.0% |
| 1996 | 393.76 Thousand AUD | 53.21% |
| 1995 | 257 Thousand AUD | -11.99% |
| 1994 | 292 Thousand AUD | 29.2% |
| 1993 | 226 Thousand AUD | 93.16% |
| 1992 | 117 Thousand AUD | 13.59% |
| 1991 | 103 Thousand AUD | -67.61% |
| 1990 | 318 Thousand AUD | 24.22% |
| 1989 | 256 Thousand AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 13.37 Million AUD | 0.0% |
| 2024 Q4 | 13.89 Million AUD | 0.0% |
| 2024 FY | 13.89 Million AUD | 17.79% |
| 2023 Q4 | 11.79 Million AUD | 0.0% |
| 2023 Q2 | 1.5 Million AUD | 0.0% |
| 2023 FY | 11.79 Million AUD | 468.57% |
| 2022 FY | 2.07 Million AUD | -73.91% |
| 2022 Q2 | 2.11 Million AUD | 0.0% |
| 2022 Q4 | 2.07 Million AUD | 0.0% |
| 2021 Q2 | 1.47 Million AUD | 0.0% |
| 2021 Q4 | 7.95 Million AUD | 0.0% |
| 2021 FY | 7.95 Million AUD | 202.39% |
| 2020 Q2 | 610.01 Thousand AUD | 0.0% |
| 2020 FY | 2.62 Million AUD | 256.45% |
| 2020 Q4 | 2.62 Million AUD | 0.0% |
| 2019 FY | 737.76 Thousand AUD | 81.38% |
| 2019 Q4 | 737.76 Thousand AUD | 0.0% |
| 2019 Q2 | 206.76 Thousand AUD | 0.0% |
| 2018 FY | 406.74 Thousand AUD | 67.99% |
| 2018 Q4 | 406.74 Thousand AUD | 0.0% |
| 2018 Q2 | 195.3 Thousand AUD | 0.0% |
| 2017 FY | 242.11 Thousand AUD | -14.36% |
| 2017 Q2 | 134.82 Thousand AUD | 0.0% |
| 2017 Q4 | 242.11 Thousand AUD | 0.0% |
| 2016 Q4 | 282.72 Thousand AUD | 0.0% |
| 2016 FY | 282.72 Thousand AUD | 47.53% |
| 2016 Q2 | 80.46 Thousand AUD | 0.0% |
| 2015 Q3 | 40.74 Thousand AUD | 0.0% |
| 2015 Q4 | 191.64 Thousand AUD | 370.37% |
| 2015 FY | 191.64 Thousand AUD | 455.57% |
| 2014 Q4 | 34.49 Thousand AUD | 0.0% |
| 2014 FY | 34.49 Thousand AUD | -25.51% |
| 2013 Q4 | 46.3 Thousand AUD | 0.0% |
| 2013 FY | 46.3 Thousand AUD | 34.13% |
| 2012 Q4 | 34.52 Thousand AUD | 0.0% |
| 2012 FY | 34.52 Thousand AUD | 23.36% |
| 2011 FY | 27.98 Thousand AUD | -39.62% |
| 2011 Q4 | 27.98 Thousand AUD | 0.0% |
| 2010 FY | 46.34 Thousand AUD | 6.9% |
| 2010 Q4 | 46.34 Thousand AUD | 0.0% |
| 2009 FY | 43.35 Thousand AUD | -96.99% |
| 2009 Q4 | 43.35 Thousand AUD | 0.0% |
| 2008 Q4 | 1.44 Million AUD | 0.0% |
| 2008 FY | 1.44 Million AUD | -45.78% |
| 2007 Q4 | 2.65 Million AUD | 0.0% |
| 2007 FY | 2.65 Million AUD | 672.86% |
| 2006 FY | 343.75 Thousand AUD | 42.94% |
| 2006 Q4 | 343.75 Thousand AUD | 0.0% |
| 2005 Q4 | 240.49 Thousand AUD | 0.0% |
| 2005 FY | 240.49 Thousand AUD | -87.96% |
| 2004 Q4 | 1.99 Million AUD | 0.0% |
| 2004 FY | 1.99 Million AUD | 12.17% |
| 2003 Q4 | 1.78 Million AUD | 0.0% |
| 2003 FY | 1.78 Million AUD | 10.79% |
| 2002 FY | 1.6 Million AUD | -1.83% |
| 2002 Q4 | 1.6 Million AUD | 0.0% |
| 2001 FY | 1.63 Million AUD | -38.46% |
| 2001 Q4 | 1.63 Million AUD | 0.0% |
| 2000 Q4 | 2.66 Million AUD | 0.0% |
| 2000 FY | 2.66 Million AUD | -20.55% |
| 1999 FY | 3.34 Million AUD | -28.18% |
| 1999 Q4 | 3.34 Million AUD | 0.0% |
| 1998 FY | 4.66 Million AUD | 1438.11% |
| 1997 Q4 | 303.21 Thousand AUD | 0.0% |
| 1997 FY | 303.21 Thousand AUD | -23.0% |
| 1996 FY | 393.76 Thousand AUD | 53.21% |
| 1995 FY | 257 Thousand AUD | -11.99% |
| 1994 FY | 292 Thousand AUD | 29.2% |
| 1993 FY | 226 Thousand AUD | 93.16% |
| 1992 FY | 117 Thousand AUD | 13.59% |
| 1991 FY | 103 Thousand AUD | -67.61% |
| 1990 FY | 318 Thousand AUD | 24.22% |
| 1989 FY | 256 Thousand AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 4.22 Million AUD | -228.507% |
| Anatara Lifesciences Ltd | 306.84 Thousand AUD | -4427.647% |
| Zelira Therapeutics Limited | 9.35 Million AUD | -48.484% |
| Biome Australia Limited | 5.37 Million AUD | -158.559% |
| Patrys Limited | 691.36 Thousand AUD | -1909.509% |
| Orthocell Limited | 22.08 Million AUD | 37.086% |
| Imugene Limited | 33.14 Million AUD | 58.082% |
| Noxopharm Limited | 1.28 Million AUD | -978.138% |
| PYC Therapeutics Limited | 10.18 Million AUD | -36.419% |
| Chimeric Therapeutics Limited | 12.8 Million AUD | -8.513% |
| Prescient Therapeutics Limited | 2.32 Million AUD | -497.405% |
| Proteomics International Laboratories Limited | 1.62 Million AUD | -754.47% |
| Cynata Therapeutics Limited | 1.17 Million AUD | -1086.369% |
| CSL Limited | 27.88 Billion AUD | 99.95% |
| Arovella Therapeutics Limited | 2.05 Million AUD | -575.523% |
| Bio-Gene Technology Limited | 368.44 Thousand AUD | -3670.712% |
| Clinuvel Pharmaceuticals Limited | 28.11 Million AUD | 50.58% |
| Starpharma Holdings Limited | 8.69 Million AUD | -59.727% |
| Nanollose Limited | 465.64 Thousand AUD | -2883.625% |
| Memphasys Limited | 5.59 Million AUD | -148.427% |
| Invex Therapeutics Ltd | 431.63 Thousand AUD | -3118.738% |
| NeuroScientific Biopharmaceuticals Limited | 85.68 Thousand AUD | -16114.464% |
| Amplia Therapeutics Limited | 3.42 Million AUD | -305.423% |
| Botanix Pharmaceuticals Limited | 3.73 Million AUD | -272.26% |
| Island Pharmaceuticals Limited | 1.04 Million AUD | -1228.684% |
| Race Oncology Limited | 1.91 Million AUD | -624.946% |
| Nyrada Inc. | 855.63 Thousand AUD | -1523.715% |
| Telix Pharmaceuticals Limited | 249.39 Million AUD | 94.429% |
| PharmAust Limited | 896.6 Thousand AUD | -1449.513% |
| Immutep Limited | 10.97 Million AUD | -26.535% |
| Clarity Pharmaceuticals Ltd | 8.33 Million AUD | -66.748% |
| Alterity Therapeutics Limited | 5.42 Million AUD | -156.061% |
| BTC Health Limited | 203.94 Thousand AUD | -6712.05% |
| Acrux Limited | 5.68 Million AUD | -144.295% |
| Neuren Pharmaceuticals Limited | 42.76 Million AUD | 67.512% |
| Biotron Limited | 737.5 Thousand AUD | -1783.781% |
| Tissue Repair Ltd | 1.35 Million AUD | -928.425% |
| AdAlta Limited | 3.54 Million AUD | -292.176% |
| Radiopharm Theranostics Limited | 44.68 Million AUD | 68.908% |
| Hexima Limited | 248.67 Thousand AUD | -5486.938% |
| AnteoTech Limited | 4.07 Million AUD | -240.912% |
| Paradigm Biopharmaceuticals Limited | 3.58 Million AUD | -287.604% |
| Recce Pharmaceuticals Ltd | 15.89 Million AUD | 12.586% |
| Avecho Biotechnology Limited | 941.54 Thousand AUD | -1375.565% |
| Actinogen Medical Limited | 1.61 Million AUD | -760.054% |
| Immuron Limited | 2.84 Million AUD | -389.101% |
| Argenica Therapeutics Limited | 2.42 Million AUD | -472.503% |